The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Follicle Stimulating Hormone Market Research Report 2024
Synopsis
Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.
The global Follicle Stimulating Hormone market was valued at US$ 1275.1 million in 2023 and is anticipated to reach US$ 1550.6 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.
Due to less pollution, recombinant FSH takes large proportion in market. In 2019, recombinant FSH takes about 82% of Poland follicle stimulating hormone consumption market share.
There are only several companies producing this product, such as Merck Serono, MSD, IBSA, Ferring, Livzon and Techwell etc. Merck Serono and MSD are Top 2 companies in the world. In 2019, Merck Serono takes about 55% of Poland follicle stimulating hormone revenue. MSD takes about 18% of Poland follicle stimulating hormone revenue.
This report aims to provide a comprehensive presentation of the global market for Follicle Stimulating Hormone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Follicle Stimulating Hormone.
Report Scope
The Follicle Stimulating Hormone market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Follicle Stimulating Hormone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Follicle Stimulating Hormone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck Serono
MSD
IBSA
Ferring
Livzon
Techwell
GenSci
Gedeon Richter
Teva
Segment by Type
Recombinant FSH
Urinary FSH
Segment by Application
Infertility Treatment
Assisted Reproductive Technology
Consumption by Region
North America
Europe
Poland
Asia-Pacific
Latin America
Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Follicle Stimulating Hormone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Follicle Stimulating Hormone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.
The global Follicle Stimulating Hormone market was valued at US$ 1275.1 million in 2023 and is anticipated to reach US$ 1550.6 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.
Due to less pollution, recombinant FSH takes large proportion in market. In 2019, recombinant FSH takes about 82% of Poland follicle stimulating hormone consumption market share.
There are only several companies producing this product, such as Merck Serono, MSD, IBSA, Ferring, Livzon and Techwell etc. Merck Serono and MSD are Top 2 companies in the world. In 2019, Merck Serono takes about 55% of Poland follicle stimulating hormone revenue. MSD takes about 18% of Poland follicle stimulating hormone revenue.
This report aims to provide a comprehensive presentation of the global market for Follicle Stimulating Hormone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Follicle Stimulating Hormone.
Report Scope
The Follicle Stimulating Hormone market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Follicle Stimulating Hormone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Follicle Stimulating Hormone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck Serono
MSD
IBSA
Ferring
Livzon
Techwell
GenSci
Gedeon Richter
Teva
Segment by Type
Recombinant FSH
Urinary FSH
Segment by Application
Infertility Treatment
Assisted Reproductive Technology
Consumption by Region
North America
Europe
Poland
Asia-Pacific
Latin America
Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Follicle Stimulating Hormone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Follicle Stimulating Hormone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Follicle Stimulating Hormone Market Overview
1.1 Product Overview and Scope of Follicle Stimulating Hormone
1.2 Follicle Stimulating Hormone Segment by Type
1.2.1 Global Follicle Stimulating Hormone Market Value Comparison by Type (2024-2030)
1.2.2 Recombinant FSH
1.2.3 Urinary FSH
1.3 Follicle Stimulating Hormone Segment by Application
1.3.1 Global Follicle Stimulating Hormone Market Value by Application: (2024-2030)
1.3.2 Infertility Treatment
1.3.3 Assisted Reproductive Technology
1.4 Global Follicle Stimulating Hormone Market Size Estimates and Forecasts
1.4.1 Global Follicle Stimulating Hormone Revenue 2019-2030
1.4.2 Global Follicle Stimulating Hormone Sales 2019-2030
1.4.3 Global Follicle Stimulating Hormone Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Follicle Stimulating Hormone Market Competition by Manufacturers
2.1 Global Follicle Stimulating Hormone Sales Market Share by Manufacturers (2019-2024)
2.2 Global Follicle Stimulating Hormone Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Follicle Stimulating Hormone Average Price by Manufacturers (2019-2024)
2.4 Global Follicle Stimulating Hormone Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Follicle Stimulating Hormone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Follicle Stimulating Hormone, Product Type & Application
2.7 Follicle Stimulating Hormone Market Competitive Situation and Trends
2.7.1 Follicle Stimulating Hormone Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Follicle Stimulating Hormone Players Market Share by Revenue
2.7.3 Global Follicle Stimulating Hormone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Follicle Stimulating Hormone Retrospective Market Scenario by Region
3.1 Global Follicle Stimulating Hormone Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Follicle Stimulating Hormone Global Follicle Stimulating Hormone Sales by Region: 2019-2030
3.2.1 Global Follicle Stimulating Hormone Sales by Region: 2019-2024
3.2.2 Global Follicle Stimulating Hormone Sales by Region: 2025-2030
3.3 Global Follicle Stimulating Hormone Global Follicle Stimulating Hormone Revenue by Region: 2019-2030
3.3.1 Global Follicle Stimulating Hormone Revenue by Region: 2019-2024
3.3.2 Global Follicle Stimulating Hormone Revenue by Region: 2025-2030
3.4 North America Follicle Stimulating Hormone Market Facts & Figures by Country
3.4.1 North America Follicle Stimulating Hormone Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Follicle Stimulating Hormone Sales by Country (2019-2030)
3.4.3 North America Follicle Stimulating Hormone Revenue by Country (2019-2030)
3.5 Europe Follicle Stimulating Hormone Market Facts & Figures by Country
3.5.1 Europe Follicle Stimulating Hormone Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Follicle Stimulating Hormone Sales by Country (2019-2030)
3.5.3 Europe Follicle Stimulating Hormone Revenue by Country (2019-2030)
3.5.4 Poland
3.6 Asia Pacific Follicle Stimulating Hormone Market Facts & Figures by Country
3.6.1 Asia Pacific Follicle Stimulating Hormone Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Follicle Stimulating Hormone Sales by Country (2019-2030)
3.6.3 Asia Pacific Follicle Stimulating Hormone Revenue by Country (2019-2030)
3.7 Latin America Follicle Stimulating Hormone Market Facts & Figures by Country
3.7.1 Latin America Follicle Stimulating Hormone Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Follicle Stimulating Hormone Sales by Country (2019-2030)
3.7.3 Latin America Follicle Stimulating Hormone Revenue by Country (2019-2030)
3.8 Middle East and Africa Follicle Stimulating Hormone Market Facts & Figures by Country
3.8.1 Middle East and Africa Follicle Stimulating Hormone Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Follicle Stimulating Hormone Sales by Country (2019-2030)
3.8.3 Middle East and Africa Follicle Stimulating Hormone Revenue by Country (2019-2030)
4 Segment by Type
4.1 Global Follicle Stimulating Hormone Sales by Type (2019-2030)
4.1.1 Global Follicle Stimulating Hormone Sales by Type (2019-2024)
4.1.2 Global Follicle Stimulating Hormone Sales by Type (2025-2030)
4.1.3 Global Follicle Stimulating Hormone Sales Market Share by Type (2019-2030)
4.2 Global Follicle Stimulating Hormone Revenue by Type (2019-2030)
4.2.1 Global Follicle Stimulating Hormone Revenue by Type (2019-2024)
4.2.2 Global Follicle Stimulating Hormone Revenue by Type (2025-2030)
4.2.3 Global Follicle Stimulating Hormone Revenue Market Share by Type (2019-2030)
4.3 Global Follicle Stimulating Hormone Price by Type (2019-2030)
5 Segment by Application
5.1 Global Follicle Stimulating Hormone Sales by Application (2019-2030)
5.1.1 Global Follicle Stimulating Hormone Sales by Application (2019-2024)
5.1.2 Global Follicle Stimulating Hormone Sales by Application (2025-2030)
5.1.3 Global Follicle Stimulating Hormone Sales Market Share by Application (2019-2030)
5.2 Global Follicle Stimulating Hormone Revenue by Application (2019-2030)
5.2.1 Global Follicle Stimulating Hormone Revenue by Application (2019-2024)
5.2.2 Global Follicle Stimulating Hormone Revenue by Application (2025-2030)
5.2.3 Global Follicle Stimulating Hormone Revenue Market Share by Application (2019-2030)
5.3 Global Follicle Stimulating Hormone Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck Serono
6.1.1 Merck Serono Corporation Information
6.1.2 Merck Serono Description and Business Overview
6.1.3 Merck Serono Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Serono Follicle Stimulating Hormone Product Portfolio
6.1.5 Merck Serono Recent Developments/Updates
6.2 MSD
6.2.1 MSD Corporation Information
6.2.2 MSD Description and Business Overview
6.2.3 MSD Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2019-2024)
6.2.4 MSD Follicle Stimulating Hormone Product Portfolio
6.2.5 MSD Recent Developments/Updates
6.3 IBSA
6.3.1 IBSA Corporation Information
6.3.2 IBSA Description and Business Overview
6.3.3 IBSA Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2019-2024)
6.3.4 IBSA Follicle Stimulating Hormone Product Portfolio
6.3.5 IBSA Recent Developments/Updates
6.4 Ferring
6.4.1 Ferring Corporation Information
6.4.2 Ferring Description and Business Overview
6.4.3 Ferring Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ferring Follicle Stimulating Hormone Product Portfolio
6.4.5 Ferring Recent Developments/Updates
6.5 Livzon
6.5.1 Livzon Corporation Information
6.5.2 Livzon Description and Business Overview
6.5.3 Livzon Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Livzon Follicle Stimulating Hormone Product Portfolio
6.5.5 Livzon Recent Developments/Updates
6.6 Techwell
6.6.1 Techwell Corporation Information
6.6.2 Techwell Description and Business Overview
6.6.3 Techwell Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Techwell Follicle Stimulating Hormone Product Portfolio
6.6.5 Techwell Recent Developments/Updates
6.7 GenSci
6.6.1 GenSci Corporation Information
6.6.2 GenSci Description and Business Overview
6.6.3 GenSci Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GenSci Follicle Stimulating Hormone Product Portfolio
6.7.5 GenSci Recent Developments/Updates
6.8 Gedeon Richter
6.8.1 Gedeon Richter Corporation Information
6.8.2 Gedeon Richter Description and Business Overview
6.8.3 Gedeon Richter Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Gedeon Richter Follicle Stimulating Hormone Product Portfolio
6.8.5 Gedeon Richter Recent Developments/Updates
6.9 Teva
6.9.1 Teva Corporation Information
6.9.2 Teva Description and Business Overview
6.9.3 Teva Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Teva Follicle Stimulating Hormone Product Portfolio
6.9.5 Teva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Follicle Stimulating Hormone Industry Chain Analysis
7.2 Follicle Stimulating Hormone Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Follicle Stimulating Hormone Production Mode & Process
7.4 Follicle Stimulating Hormone Sales and Marketing
7.4.1 Follicle Stimulating Hormone Sales Channels
7.4.2 Follicle Stimulating Hormone Distributors
7.5 Follicle Stimulating Hormone Customers
8 Follicle Stimulating Hormone Market Dynamics
8.1 Follicle Stimulating Hormone Industry Trends
8.2 Follicle Stimulating Hormone Market Drivers
8.3 Follicle Stimulating Hormone Market Challenges
8.4 Follicle Stimulating Hormone Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
